Showing 1881-1890 of 2050 results for "".
- ECPs Can Now Access Online Training to Certify to Prescribe CooperVision’s Brilliant Futures Myopia Management Programhttps://modernod.com/news/ecps-can-now-access-online-training-to-certify-to-prescribe-coopervisions-brilliant-futures-myopia-management-program/2477762/This month, CooperVision unveiled an online training curriculum so eye care professionals (ECPs) can certify to prescribe the Brilliant Futures Myopia Management Program featuring MiSight 1 day contact lenses. CooperVision will continue outreach to ECPs who have experience with pediatric populati
- The Vision Council Releases April COVID-19 Optical Impact Consumer Studyhttps://modernod.com/news/the-vision-council-releases-april-covid-19-optical-impact-consumer-study/2477763/The Vision Council has released the results of the April COVID-19 Optical Impact Consumer Study. The study, which launched in February and has continued since then as part of The Vision Council’s monthly VisionWatch consumer survey, gauges consumers’ level of concern about the COVID-19 pandemic a
- RegeneRx Joint Venture Announces Efficacy Results of Neurotrophic Keratopathy Phase 3 Clinical Trial with RGN-259https://modernod.com/news/regenerx-joint-venture-announces-efficacy-results-of-neurotrophic-keratopathy-phase-3-clinical-trial-with-rgn-259/2477764/ReGenTree LLC, a US joint venture company owned by GtreeBNT Co. and RegeneRx Biopharmaceuticals, announced the results of a randomized, double masked, placebo-controlled phase 3 clinical trial (SEER-1) using RGN-259 for the treatment of neurotrophic keratopathy (NK).
- Scientists Find Eye Cells Are a Prime Target for COVID-19 to Attach Tohttps://modernod.com/news/scientists-find-eye-cells-are-a-prime-target-for-covid-19-to-attach-to/2477736/Scientists have claimed the coronavirus can enter the body through the eyes after finding they contain a protein used by the infection to bind to cells, according to a
- Three Potential Futures For COVID-19: Recurring Small Outbreaks, a Monster Wave, or a Persistent Crisishttps://modernod.com/news/three-potential-futures-for-covid-19-recurring-small-outbreaks-a-monster-wave-or-a-persistent-crisis/2477716/As epidemiologists attempt to scope out what COVID-19 has in store for the U.S. this summer and beyond, they see several potential futures, differing by how often and how severely the no-longer-new coronavirus continues to wallop humankind, according to a Stat News
- Foundation Fighting Blindness To Jointly Host Online CME, COPE Webinarhttps://modernod.com/news/foundation-fighting-blindness-to-jointly-host-online-cme-cope-webinar/2477657/The Foundation Fighting Blindness has announced it will host its first continuing medical education (CME and COPE) event. The distance-learning course will be hosted on Monday, May 18, 2020 at 12 pm eastern time. The course will cover inherited retinal diseases (IRDs), Foundation resources, and c
- CDC Adds 6 Symptoms To Its COVID-19 Listhttps://modernod.com/news/cdc-adds-6-symptoms-to-its-covid-19-list/2477651/The Centers for Disease Control and Prevention (CDC) has added several new symptoms to its existing list of symptoms for COVID-19, according to an NPR report. T
- NIH to Launch Public-Private Partnership to Speed COVID-19 Vaccine and Treatment Optionshttps://modernod.com/news/nih-to-launch-public-private-partnership-to-speed-covid-19-vaccine-and-treatment-options/2477612/The National Institutes of Health and the Foundation for the NIH (FNIH) are bringing together more than a dozen leading biopharmaceutical companies, along with the Health and Human Services Office of the Assistant Secretary for Preparedness and Response, the Centers for Disease Control and Preven
- How to Sanitize N95 Masks for Reuse: NIH Studyhttps://modernod.com/news/how-to-sanitize-n95-masks-for-reuse-nih-study/2477607/Exposing contaminated N95 respirators to vaporized hydrogen peroxide (VHP) or ultraviolet (UV) light appears to eliminate the SARS-CoV-2 virus from the material and preserve the integrity of the masks’ fit for up to three uses, a National Institutes of Health (NIH)
- Leo Lens Pharma Appoints Dan Myers CEOhttps://modernod.com/news/leo-lens-pharma-appoints-dan-myers-ceo/2477589/Leo Lens Pharma has announced the appointment of Dan Myers as Chief Executive Officer. Prior to joining Leo Lens, Mr. Myers was the co-founder and Chief Executive Officer of Alimera Sciences, where he continues to serve as chairman of the Board of Directors. Before founding Alimera, Mr. Myers was
